Posted in | News | Gold | Mining Business

NWB Commences Review of Sabina Gold & Silver’s Water License Applications for Back River Project

Sabina Gold & Silver Corp,  is pleased to announce that the Nunavut Water Board (NWB) has commenced public review of the Type A and Type B water license applications related to initial development, mine construction and operation of the Back River Project.

As announced on December 6, 2017, the Minister of Indigenous and Northern Affairs Canada, on behalf of the five responsible federal Ministers, accepted Nunavut Impact Review Board’s recommendation for the Project to proceed to the regulatory and licensing phase.  The NIRB has advised that the final Project Certificate will be issued on or before January 4, 2018.

The Type B water license would enable Sabina to commence certain initial pre-development activities in 2018 including onsite construction of service roads and laydown pads, and the mobilization of fuel, supplies and equipment at the Goose property and marine laydown area.  Sabina anticipates approval of the Type B water license in late Q1, 2018.

The Type A water license would allow for full construction and operation of the Back River project.  Sabina anticipates approval of the Type A water license in Q4, 2018.

“With a positive Ministers decision now in hand we are pleased to see that the licensing process has commenced which will enable full development of the Back River Project” said Bruce McLeod, President & CEO.  “We look forward to receiving the Project Certificate, various final licenses as well as finalizing the definitive agreements with the Kitikmeot Inuit Association for land tenure and Inuit benefits.”

Source: http://www.sabinagoldsilver.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.